Skip to main content

1 Result(s)

within Li Yating Remove this filter Medicine & Public Health Remove this filter

and

  1. No Access

    Article

    Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma is safe and confers clinical benefit

    Epstein-Barr virus (EBV) is associated with nasopharyngeal carcinoma (NPC), and provides a target for a dendritic cell (DC) vaccine. CD137 ligand (CD137L) expressed on antigen presenting cells, costimulates CD...

    Emily Nickles, Bhushan Dharmadhikari, Li Yating… in Cancer Immunology, Immunotherapy (2022)